TYMP and mitochondrial neurogastrointestinal encephalomyopathy: More recently, it has been reported that treatment with AAV2/8-mediated transfer of the human TYMP coding sequence (hcTYP) targeting the liver in a murine model provides a permanent biochemical correction without adverse effects, which further indicates that gene therapy is a feasible therapeutic option for MNGIE treatment [65].